Rising Prevalence of Diabetes and Osteoarthritis is Escalating the Germany Peptide Therapeutics Market
Published: Nov 2020
The German peptide therapeutics market will see a considerable growth of 5.0% during the forecast period. As per the report published by the German Diabetes Center (DDZ), in 2019 more than 7.2% of the population in Germany suffered from diabetes, most of them suffering from Type 2 diabetes. The report estimates that the number of individuals with diabetes will increase significantly in the next two decades.
Substantial Prevalence of Chronic Diseases will Escalate the European Peptide Therapeutics Market
Published: Nov 2020
The European peptide therapeutics market will see a considerable growth of 4.3% during the forecast period. The region has a significant presence of peptide therapeutics industry players, with extensive R&D in the market. With the increase in the number of cases of cancer in the region, the demand for proper treatment and availability of drugs is expected to rise; thereby, augmenting the growth of peptide therapeutics for cancer treatment.
Significant Presence of Healthcare CROs in Chinais Escalating China Peptide Therapeutics Market
Published: Nov 2020
China's peptide therapeutics market will see a considerable growth of 6.8% during the forecast period. Since the last decade, China has emerged as a globally preferred destination for the outsourcing of drug research. The robust growth of China’s Contract Research (CRO) industry is encouraging the transition of outsourcing services at a large scale, thereby contributing to drug innovation.
Research and Events for Peptides will Escalate the Asia-Pacific Peptide Therapeutics Market
Published: Nov 2020
The Asia-Pacific peptide therapeutics market will see a considerable growth of 6.7% during the forecast period. Asia-Pacific is one of the promising regions in the field of peptides. The frequent collaboration of various global and domestic companies through workshops and seminars is also expected to present a new growth opportunity for the Asia-Pacific peptide therapeutics market.
Easy Availability of the Medical Devices in the Region to Brace the European Injection Pen Market Growth
Published: Nov 2020
The European injection pen market is anticipated to grow at a CAGR of 7.4% over the forecast period (2020-2026). The key factors that drive the growth of the market in the region include easy availability of these devices in the region owing to the presence of key players such as Sanofi SA, Novo Nordisk AS, F. Hoffmann-La Roche Ltd. among many others which are pioneers in innovation, design, and manufacture of the injection pen.
Huge Population and Large Pool of Diabetic Patients Creates Scope for Asia-Pacific Injection Pen Market Growth
Published: Nov 2020
The Asia-Pacific injection pen market is anticipated to grow at a CAGR of 8.1% over the forecast period (2020-2026). The key factors that drive the growth of the injection pen industry in the Asia-Pacific region include the huge population and a large pool of diabetic patients in the region. As per the World Bank 2020, China is the second-largest economy after the US and has the world’s largest population of approximately 1.4 billion, followed by India of approximately 1.3 billion.
Autoimmune Disorders Segment to Contribute to the Global Injection Pen Market Growth
Published: Nov 2020
The global injection pen market is anticipated to grow at a CAGR of 6.8% over the forecast period (2020-2026). The market is segmented on the basis of type and disorder type. Based on the disorder type, the market is segmented into diabetes, hormonal disorders, arthritis, and others. The diabetes segment of the market is estimated to witness significant growth in the market.
US Neurological Disorder Drugs Market Growth Factors
Published: Nov 2020
The US neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). Rising cases of neurological disorders, geriatric population, and rapid advancement by the key players operating in the neurological disorder drugs landscape are some of the key factors that drive the growth of the US neurological disorder drugs industry.
Key Players to Considerably Contribute to the North American Neurological Disorder Drugs Market
Published: Nov 2020
The North American neurological disorder drug industry is growing significantly over the forecast period (2020-2026) owing to the rising prevalence of neurological disorders, rising geriatric population, rapid R&D activities by the players in the region. For instance, in May 2019, Allergan Plc announced to share approximately 29 presentations at the 71st Annual American Academy of Neurology (AAN) Meeting regarding neurological disorders and their treatment options.
Increasing Burden of Neurological Disorders to Support Indian Neurological Disorder Drugs Market Growth
Published: Nov 2020
The Indian neurological disorder drugs market is anticipated to grow significantly over the forecast period (2020-2026). The key factor that primarily flourishes the growth of the Indian neurological disorder drugs industry includes the rising prevalence of neurological disorders. There is an increased burden of neurological disorders in the country, along with the lack of skilled personnel for the treatment and prescriptions.